Pre-weaning carvedilol treatment in spontaneously hypertensive rats

European Journal of Pharmacology

Volumn 486, Issue 2, 2004, Pages 183-188

  Boesen, Erika I ^a   Lambert, Gavin W ^b   Anderson, Warwick P ^a   Kett, Michelle M ^a  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Andrenoceptor antagonist; Spontaneously hypertensive rat (SHR); Sympathetic nervous system

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL;

ADRENERGIC SYSTEM; ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DRUG EFFECT; ESSENTIAL HYPERTENSION; EYE MOVEMENT; FEMALE; GROWTH RETARDATION; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; WEANING;

EID: 1242306190     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.12.012     Document Type: Article

References (19)

1. Bergstrom G., Johansson I., Stevenson K.M., Kett M.M., Anderson W.P. Perindopril treatment affects both preglomerular renal vascular lumen dimensions and in vivo responsiveness to vasoconstrictors in spontaneously hypertensive rats. Hypertension. 31:1998;1007-1013.
2. Boesen E.I., Lewis T.V., Kett M.M., Anderson W.P. Effects of preweaning doxazosin treatment on adult pressure in the spontaneously hypertensive rat. Clin. Exp. Pharmacol. Physiol. 30:2003;555-557.
3. Burrell L.M., Phillips P.A., Risvanis J., Aldred K.L., Hutchins A.M., Johnston C.I. Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism. Hypertension. 26:1995;828-834.
4. Erlinge D., Yoo H., Edvinsson L., Reis D.J., Wahlestedt C. Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am. J. Physiol. 265:1993;H1089-H1097.
5. Fan X.M., Hendley E.D., Forehand C.J. Enhanced vascular neuropeptide Y-immunoreactive innervation in two hypertensive rat strains. Hypertension. 26:1995;758-763.
6. Gavras I., Manolis A.J., Gavras H. The alpha2-adrenergic receptors in hypertension and heart failure: experimental and clinical studies. J. Hypertens. 19:2001;2115-2124.
7. Guyton A.C., Coleman T.G., Cowley A.V. Jr., Scheel K.W., Manning R.D. Jr., Norman R.A. Jr. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am. J. Med. 52:1972;584-594.
8. Hancock A.A., Buckner S.A., Ireland L.M., Knepper S.M., Kerwin J.F. Jr. Actions of terazosin and its enantiomers at subtypes of alpha 1- and alpha 2-adrenoceptors in vitro. J. Recept. Signal Transduct. Res. 15:1995;863-885.
9. Korner P.I., Bobik A., Oddie C.J., Friberg P. Sympathoadrenal system is critical for structural changes in genetic hypertension. Hypertension. 22:1993;243-252.
10. Lee R.M., Triggle C.R., Cheung D.W., Coughlin M.D. Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats. Hypertension. 10:1987;328-338.
11. Lee R.M., Borkowski K.R., Leenen F.H., Tsoporis J., Coughlin M. Combined effect of neonatal sympathectomy and adrenal demedullation on blood pressure and vascular changes in spontaneously hypertensive rats. Circ. Res. 69:1991;714-721.
12. Lee R.M.K.W., Tsoporis J., Wang R.J. Influence of chronic nadolol treatment on blood pressure and vascular changes in spontaneously hyertensive rats. Can. J. Physiol. Pharm. 70:1992;1261-1270.
13. McCarty R., Lee J.H. Preweanling administration of terazosin decreases blood pressure of hypertensive rats in adulthood. Hypertension. 27:1996;1115-1120.
14. Medvedev O.S., Esler M.D., Angus J.A., Cox H.S., Eisenhofer G. Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol. 341:1990;192-199.
15. Michel M.C., Rascher W. Neuropeptide Y: a possible role in hypertension? J. Hypertens. 13:1995;385-395.
16. Ohlstein E.H., Vickery L., Arleth A., Barone F., Sung C.P., Camden A., McCartney L. Carvedilol, a novel cardiovascular agent, inhibits development of vascular and ventricular hypertrophy in spontaneously hypertensive rats. Clin. Exp. Hypertens. 16:1994;163-177.
17. Oliver J.R., Korner P.I., Woods R.L., Zhu J.L. Reflex release of vasopressin and renin in hemorrhage is enhanced by autonomic blockade. Am. J. Physiol. 258:1990;H221-H228.
18. Ruffolo R.R.J., Gellai M., Hieble J.P., Willette R.N., Nichols A.J. The pharmacology of carvedilol. Eur. J. Clin. Pharmacol. 38:1990;S82-S88.
19. Tomoda F., Bergstrom G., Evans R.G., Anderson W.P. Evidence for decreased structurally determined preglomerular resistance in the young spontaneously hypertensive rat after 4 weeks of renal denervation. J. Hypertens. 15:1997;1187-1195.